Stock listing

TPEx:6634 Sinew Pharma, Inc. (欣耀) 股價

Follow Sinew Pharma, Inc. into a list and get an email when it puts out news.

Share price · TPEX:6634

$52.90 TWD -7.10 (-11.8%)

Close on Nov 20, 2026

This year +31.9% · daily closes, Dec 1, 2025 – Nov 20, 2026, adjusted for splits
Day range
$50.90 – $57.00 TWDNov 20, 2026
Volume
233,635 sharesNov 20, 2026
Market cap
$3.77B TWDAt the close on Nov 20, 2026 · price × 71.29M shares outstanding
Traded on an average day
$6.08M TWDMedian day 77,785 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Sinew Pharma, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6634 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$52.90-7.10-11.8%$57.00$57.00$50.90233,635
$60.00+2.30+4.0%$58.00$61.80$58.00204,625
$57.70-1.30-2.2%$59.00$59.00$56.30106,126
$59.00-0.90-1.5%$59.90$59.90$56.30144,375
$59.90-0.40-0.7%$60.40$60.40$58.8042,605
$60.30-2.90-4.6%$63.30$65.20$58.30199,549
$63.20+6.00+10.5%$57.20$64.90$56.00363,837
$57.20+0.50+0.9%$56.70$58.00$55.1044,422
$56.70+1.20+2.2%$55.50$56.80$54.3076,151
$55.50+2.00+3.7%$52.50$55.50$47.65115,662
$53.50-2.30-4.1%$56.00$56.10$52.4085,939
$55.80-0.40-0.7%$56.40$57.80$53.5097,995
$56.20-2.00-3.4%$58.00$59.20$54.5087,026
$58.20+4.20+7.8%$54.00$58.50$53.8079,419
$54.00-1.70-3.1%$55.70$55.70$52.8088,920
$55.70-0.10-0.2%$55.70$55.80$54.1015,172
$55.80-1.20-2.1%$57.00$57.00$55.0038,951
$57.00+1.50+2.7%$55.60$57.20$54.8069,529
$55.50+0.10+0.2%$55.50$55.50$55.500
$55.40-2.30-4.0%$57.80$58.20$53.9095,505
$57.70-0.10-0.2%$57.90$58.30$56.5049,126
$57.80-0.40-0.7%$58.20$58.20$56.3016,226
$58.20-1.50-2.5%$59.90$60.00$56.3056,557
$59.70+2.90+5.1%$58.00$61.10$58.0056,150
$56.80-3.40-5.6%$60.20$60.20$55.80112,755
$60.200.000.0%$60.00$60.20$58.0073,053
$60.20-0.60-1.0%$60.80$60.80$58.1036,545
$60.80+0.80+1.3%$60.20$60.80$58.5040,788
$60.00-0.60-1.0%$60.80$61.50$59.6073,369
$60.60-1.20-1.9%$61.40$64.20$59.90108,944
$61.80-2.10-3.3%$64.40$64.40$61.8091,981
$63.90-2.30-3.5%$65.30$66.20$62.00146,612
$66.20+4.60+7.5%$61.70$70.10$61.00346,758
$61.60+0.50+0.8%$61.50$61.90$60.00109,806
$61.10+1.10+1.8%$60.20$62.50$59.80172,324
$60.000.000.0%$60.00$60.40$58.8054,486
$60.000.000.0%$60.00$61.20$58.8056,915
$60.00+1.80+3.1%$60.00$61.00$58.8026,546
$58.20-2.40-4.0%$60.60$61.30$57.6065,414
$60.60+3.60+6.3%$57.00$61.20$57.00141,473
$57.00-1.90-3.2%$60.20$60.20$56.90113,155
$58.90-0.30-0.5%$59.00$60.00$57.80151,723
$59.20+3.50+6.3%$56.00$60.30$56.00109,273
$55.70-4.50-7.5%$58.30$59.00$54.60164,231
$60.20+9.20+18.0%$51.00$66.00$51.00446,084
$51.00+1.05+2.1%$50.00$51.00$47.5559,433
$49.95-0.25-0.5%$50.20$50.30$48.8045,057
$50.20-3.30-6.2%$53.50$53.50$48.30419,790
$53.50+1.80+3.5%$52.00$54.50$52.0046,049
$51.70-0.10-0.2%$51.10$51.70$50.5049,185
$51.80-0.70-1.3%$52.00$52.00$50.6096,666
$52.50-3.20-5.7%$55.80$55.80$51.80216,087
$55.70-0.30-0.5%$56.00$56.20$54.6045,967
$56.00-2.40-4.1%$57.00$57.90$55.10130,294
$58.40-1.60-2.7%$60.00$60.00$57.0073,422
$60.00+0.10+0.2%$58.80$60.20$58.6018,240
$59.90+1.10+1.9%$58.80$59.90$57.9027,703
$58.80-0.90-1.5%$60.00$60.20$57.8055,955
$59.70-0.50-0.8%$60.20$60.20$58.6028,460
$60.20+0.10+0.2%$60.90$63.20$58.80115,553
$60.10+0.10+0.2%$60.00$60.90$58.8031,331
$60.00+0.10+0.2%$60.00$60.00$57.0014,595
Ticker
TPEx:6634
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TPEx
Currency
TWD

Sinew Pharma, Inc. on 6ix

Sector
Health care
Industry
Biotechnology

Valuation

EV/sales 59,064× against a median of 9.9×: the highest of 8 Biotechnology companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$2.78B TWD
P/E
Loss
EV/sales
59,064×
EV/EBITDA
Negative EBITDA
Price/book
3.6×
Gross margin
78.7%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Sinew Pharma, Inc. · TPEX:6634US$114.4MUS$84.23Mn/a59,064×n/a3.6×n/a0.0×n/a
STCube, Inc. · KRX:052020US$118.4MUS$72.43Mn/a13.6×n/a2.6×−338.7%0.0×n/a
Atrium Therapeutics, Inc. · NASDAQ:RNAUS$118.4M−US$113.0Mn/a−2.9×n/a0.6×−229.7%0.0×0.76
Adagene, Inc. · NASDAQ:ADAGUS$118.2M−US$3.65Mn/a−0.5×n/a1.1×−229.6%0.1×1.43
Curacle Co., Ltd. · KRX:365270US$117.6MUS$100.4Mn/a16.3×n/a3.4×−92.1%0.0×n/a
PegBio Co., Ltd. Class H · HKEX:2565US$117.2MUS$55.97Mn/an/an/a2.9×n/a0.0×n/a
enGene Therapeutics Inc. · NASDAQ:ENGNUS$116.6M−US$149.7Mn/an/an/a0.5×n/a0.0×1.82
Armata Pharmaceuticals, Inc. · AMEX:ARMPUS$112.7MUS$346.0Mn/a45.8×n/an/an/an/a0.97
Medigen Biotechnology Corporation · TPEX:3176US$111.8MUS$61.95Mn/a1.6×n/a2.5×−19.9%0.8×n/a
Fate Therapeutics, Inc. · NASDAQ:FATEUS$111.7MUS$47.08Mn/a9.9×n/a0.8×n/a0.6×2.25
OnKure Therapeutics, Inc. · NASDAQ:OKURUS$109.4M−US$53.16Mn/an/an/a0.7×n/a0.0×1.17
Median of the othersUS$116.9MUS$51.52M9.9×1.1×−229.6%0.0×1.30

Team and board

Officers

OfficerRole
Kai-Min ChuChairman & CEO
Tzu-Wen ChenChief Financial Officer
Cheng-Huei HsiongChief Operating Officer
Chi-Chi ChouDirector of Quantitative Analysis Department
Hsin-Tien HoChief Technology Officer

Board

DirectorRole
Kai-Min ChuChairman & CEO

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue47.0K00328.0K6.23M462.0K
Cost of revenue10.0K30.3M29.0M38.0K1.14M138.0K
Gross profit37.0K-30.3M-29.0M290.0K5.09M324.0K
Research and development97.5M113.6M133.5M114.6M72.7M66.7M60.3M
Selling, general and administrative42.7M37.0M34.7M34.1M26.8M17.7M16.6M
Operating income-140.1M-168.9M-186.3M-148.4M-94.4M-84.1M-76.0M
Depreciation and amortization19.3M30.3M29.0M22.8M22.6M21.9M18.3M
EBITDA-120.8M-138.6M-157.3M-125.6M-71.8M-62.3M-57.8M
Interest expense657.0K414.0K776.0K275.0K146.0K274.0K176.0K
Income before tax-123.7M-150.4M-170.9M-140.2M-91.6M-82.0M-76.2M
Net income-123.7M-150.4M-170.9M-140.2M-91.6M-82.0M-76.2M
Earnings per share, basic-1.74-2.11-2.43-2.02-1.54-1.60-1.94

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents25.3M41.4M166.8M246.7M551.2M46.8M252.7M
Short-term investments1.03B1.12B1.11B1.14B931.5M291.5M40.0M
Receivables50.0K2.42M1.85M1.22M433.0K153.0K
Current assets1.08B1.18B1.30B1.41B1.50B351.9M305.9M
Total assets1.13B1.23B1.36B1.49B1.58B453.2M420.8M
Current liabilities25.5M27.2M35.2M23.3M15.1M15.5M247.8M
Total debt2.82M9.28M7.54M1.05M3.34M5.18M
Total liabilities36.4M28.9M39.7M28.7M16.0M17.4M252.0M
Shareholders' equity1.09B1.20B1.32B1.46B1.57B435.8M168.8M
Shares outstanding71.3M71.3M70.5M69.3M59.5M51.3M39.4M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-95.3M-106.1M-118.0M-93.8M-57.3M-59.3M-58.7M
Capital spending-1.87M-1.33M-7.45M-5.88M-5.87M-2.69M-6.66M
Free cash flow-97.2M-107.4M-125.5M-99.6M-63.2M-62.0M-65.4M
Cash from investing-16.7M26.2M-221.1M-648.6M-256.7M34.0M
Cash from financing-2.65M12.0M10.4M1.21B110.1M235.7M
Change in cash-16.1M-125.4M-79.9M-304.5M504.3M-205.9M210.9M

Open Financials

Cap table

Built by 6ix from Sinew Pharma, Inc.’s releases

Common shares
71,288,930
Fully diluted
71,288,930

Fully diluted

LineShares
Common shares71,288,930

Share count over time

CountShares
Nov 22, 202671,288,930

Open Cap table

Shareholders

HolderSharesOf the companyAs of
佳峻投資股份有限公司6.35M8.9%Oct 31, 2026
楊宇浩3.6M5.1%Oct 31, 2026
哥羅西實業股份有限公司2.55M3.6%Oct 31, 2026
朱凱民1.79M2.5%Oct 31, 2026
熊正輝519K0.73%Oct 31, 2026
聯鼎資本投資有限合夥346K0.49%Oct 31, 2026
何欣恬128K0.18%Oct 31, 2026
周繼祺28,9500.04%Oct 31, 2026
陳姿文14,6500.02%Oct 31, 2026
韓立群00.00%Oct 31, 2026
All 15 holders
HolderSharesOf the companyAs of
郭漢彬00.00%Oct 31, 2026
馬寶琳00.00%Oct 31, 2026
高明見00.00%Oct 31, 2026
劉玄哲00.00%Oct 31, 2026
邱聰智00.00%Oct 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Cheng-Huei HsiongChief Operating Officer · Since at least Nov 5, 2026
Chi-Chi ChouDirector of Quantitative Analysis Department · Since at least Nov 5, 2026
Hsin-Tien HoChief Technology Officer · Since at least Nov 5, 2026
Kai-Min ChuChairman & CEO · Since at least Nov 5, 2026
Tzu-Wen ChenChief Financial Officer · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Sinew Pharma, Inc.